#therapies

Collection of therapies news, found 184 news.

Invicro LLC announces Dr. Matthew Silva as new Chief Executive Officer and Dr. Jack Hoppin is named President of Konica Minolta Precision Medicine

- Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief ...

Macrogen Research outcome from ‘GenomeAsia 100K’ covered in Nature

- The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo, www.macrogen.com) (KOSDAQ: 038290) ...

Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

The Mary Kay Foundation donates $100,000 to Baylor Scott & White to support triple negative breast cancer research

- The Mary Kay FoundationSM, a decades-long leader in the mission to eliminate cancers affecting women, recently ...

Takeda agrees to divest select OTC and non-core assets to Acino for over $200 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

Hansoh Pharma and Atomwise launch strategic AI drug discovery collaboration for multiple therapeutic areas

- Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and ...

Aptorum Group announces the development of microbiome drug candidate targeting obesity and repurposed drug candidates targeting neuroblastoma

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Takeda completes sale of Xiidra® to Novartis

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its sale ...

Terns Pharmaceuticals appoints Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer

- Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative ...

Terns Pharmaceuticals announces exclusive licensing and collaboration agreement with GENFIT to develop and commercialize elafibranor in the Greater China region

- Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a ...

Terns Pharmaceuticals initiates a Phase 1 clinical trial of TERN-101

- Terns Pharmaceuticals, Inc. today announced the initiation of a Phase 1 clinical trial of TERN-101, an farnesoid X ...

Q3 Medical Devices Limited enters into a distribution agreement with Medtronic for its biodegradable biliary and pancreatic stent

- Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a ...

Takeda simplifies portfolio and accelerates deleveraging through two divestitures

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into ...

Bali remains world's favorite tourist destination

The resort island of Bali in Indonesia remains a favorite tourist spot for foreigners to invest in the tourism ...

Terns Pharmaceuticals to present at BioCentury’s 26th Annual Future Leaders in Biotech Industry Conference

- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...